vs
Side-by-side financial comparison of Crexendo, Inc. (CXDO) and FONAR CORP (FONR). Click either name above to swap in a different company.
FONAR CORP is the larger business by last-quarter revenue ($25.5M vs $18.1M, roughly 1.4× Crexendo, Inc.). FONAR CORP runs the higher net margin — 8.0% vs 6.7%, a 1.3% gap on every dollar of revenue. On growth, Crexendo, Inc. posted the faster year-over-year revenue change (11.2% vs 2.4%). Over the past eight quarters, Crexendo, Inc.'s revenue compounded faster (12.4% CAGR vs -0.3%).
Crexendo, Inc. is a U.S.-headquartered cloud communications technology provider. It delivers unified communications as a service (UCaaS), contact center solutions, business VoIP services, and collaborative work tools, primarily catering to small and medium-sized enterprises operating in the North American market.
FONAR Corp is a specialized medical technology firm that designs, manufactures, and distributes innovative MRI systems including upright and open models. It primarily serves U.S. hospitals, diagnostic imaging centers, and healthcare providers, delivering high-precision scanning solutions for clinical diagnostic use.
CXDO vs FONR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $18.1M | $25.5M |
| Net Profit | $1.2M | $2.1M |
| Gross Margin | — | — |
| Operating Margin | 6.3% | 13.5% |
| Net Margin | 6.7% | 8.0% |
| Revenue YoY | 11.2% | 2.4% |
| Net Profit YoY | 140.2% | 4.7% |
| EPS (diluted) | $0.03 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $18.1M | $25.5M | ||
| Q3 25 | $17.5M | $26.0M | ||
| Q2 25 | $16.6M | $27.3M | ||
| Q1 25 | $16.1M | $27.2M | ||
| Q4 24 | $16.2M | $24.9M | ||
| Q3 24 | $15.6M | $25.0M | ||
| Q2 24 | $14.7M | $25.9M | ||
| Q1 24 | $14.3M | $25.7M |
| Q4 25 | $1.2M | $2.1M | ||
| Q3 25 | $1.4M | $2.3M | ||
| Q2 25 | $1.2M | $729.3K | ||
| Q1 25 | $1.2M | $2.5M | ||
| Q4 24 | $507.0K | $2.0M | ||
| Q3 24 | $148.0K | $3.1M | ||
| Q2 24 | $588.0K | $830.4K | ||
| Q1 24 | $434.0K | $1.9M |
| Q4 25 | 6.3% | 13.5% | ||
| Q3 25 | 7.5% | 14.1% | ||
| Q2 25 | 6.7% | 5.3% | ||
| Q1 25 | 7.2% | 15.2% | ||
| Q4 24 | 3.9% | 11.9% | ||
| Q3 24 | 0.9% | 21.0% | ||
| Q2 24 | 3.9% | 7.4% | ||
| Q1 24 | 3.4% | 16.8% |
| Q4 25 | 6.7% | 8.0% | ||
| Q3 25 | 8.3% | 8.7% | ||
| Q2 25 | 7.4% | 2.7% | ||
| Q1 25 | 7.3% | 9.2% | ||
| Q4 24 | 3.1% | 7.9% | ||
| Q3 24 | 0.9% | 12.6% | ||
| Q2 24 | 4.0% | 3.2% | ||
| Q1 24 | 3.0% | 7.3% |
| Q4 25 | $0.03 | — | ||
| Q3 25 | $0.05 | — | ||
| Q2 25 | $0.04 | — | ||
| Q1 25 | $0.04 | — | ||
| Q4 24 | $0.03 | — | ||
| Q3 24 | $0.00 | — | ||
| Q2 24 | $0.02 | — | ||
| Q1 24 | $0.01 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $121.0K |
| Total DebtLower is stronger | $114.0K | — |
| Stockholders' EquityBook value | $63.8M | $176.9M |
| Total Assets | $77.7M | $217.2M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $121.0K | ||
| Q3 25 | — | $122.0K | ||
| Q2 25 | — | $56.5M | ||
| Q1 25 | — | $123.0K | ||
| Q4 24 | — | $121.0K | ||
| Q3 24 | — | $136.0K | ||
| Q2 24 | — | $56.5M | ||
| Q1 24 | — | $134.0K |
| Q4 25 | $114.0K | — | ||
| Q3 25 | $236.0K | — | ||
| Q2 25 | $356.0K | — | ||
| Q1 25 | $475.0K | — | ||
| Q4 24 | $592.0K | — | ||
| Q3 24 | $709.0K | — | ||
| Q2 24 | $823.0K | $66.9K | ||
| Q1 24 | $937.0K | — |
| Q4 25 | $63.8M | $176.9M | ||
| Q3 25 | $61.3M | $174.9M | ||
| Q2 25 | $58.3M | $172.6M | ||
| Q1 25 | $55.2M | $171.9M | ||
| Q4 24 | $51.4M | $169.8M | ||
| Q3 24 | $49.5M | $168.7M | ||
| Q2 24 | $48.2M | $166.0M | ||
| Q1 24 | $46.8M | $165.8M |
| Q4 25 | $77.7M | $217.2M | ||
| Q3 25 | $76.0M | $218.4M | ||
| Q2 25 | $71.4M | $216.9M | ||
| Q1 25 | $67.4M | $214.9M | ||
| Q4 24 | $64.9M | $208.0M | ||
| Q3 24 | $62.3M | $212.3M | ||
| Q2 24 | $59.6M | $214.2M | ||
| Q1 24 | $57.5M | $209.6M |
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.01× | — | ||
| Q1 25 | 0.01× | — | ||
| Q4 24 | 0.01× | — | ||
| Q3 24 | 0.01× | — | ||
| Q2 24 | 0.02× | 0.00× | ||
| Q1 24 | 0.02× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.3M | $171.0K |
| Free Cash FlowOCF − Capex | — | $-227.0K |
| FCF MarginFCF / Revenue | — | -0.9% |
| Capex IntensityCapex / Revenue | 0.0% | 1.6% |
| Cash ConversionOCF / Net Profit | 1.93× | 0.08× |
| TTM Free Cash FlowTrailing 4 quarters | — | $5.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.3M | $171.0K | ||
| Q3 25 | $4.4M | $1.7M | ||
| Q2 25 | $1.3M | $4.2M | ||
| Q1 25 | $1.2M | $3.1M | ||
| Q4 24 | $2.2M | $2.2M | ||
| Q3 24 | $1.6M | $1.7M | ||
| Q2 24 | $2.7M | $4.6M | ||
| Q1 24 | $-166.0K | $2.8M |
| Q4 25 | — | $-227.0K | ||
| Q3 25 | — | $-177.0K | ||
| Q2 25 | $1.3M | $3.6M | ||
| Q1 25 | — | $2.6M | ||
| Q4 24 | $2.1M | $1.5M | ||
| Q3 24 | — | $-148.0K | ||
| Q2 24 | — | $4.2M | ||
| Q1 24 | — | $2.6M |
| Q4 25 | — | -0.9% | ||
| Q3 25 | — | -0.7% | ||
| Q2 25 | 7.7% | 13.1% | ||
| Q1 25 | — | 9.4% | ||
| Q4 24 | 13.2% | 6.0% | ||
| Q3 24 | — | -0.6% | ||
| Q2 24 | — | 16.1% | ||
| Q1 24 | — | 10.2% |
| Q4 25 | 0.0% | 1.6% | ||
| Q3 25 | 0.0% | 7.2% | ||
| Q2 25 | 0.1% | 2.4% | ||
| Q1 25 | 0.0% | 2.2% | ||
| Q4 24 | 0.2% | 3.0% | ||
| Q3 24 | 0.0% | 7.2% | ||
| Q2 24 | 0.0% | 1.6% | ||
| Q1 24 | 0.0% | 0.7% |
| Q4 25 | 1.93× | 0.08× | ||
| Q3 25 | 3.05× | 0.75× | ||
| Q2 25 | 1.05× | 5.79× | ||
| Q1 25 | 1.06× | 1.26× | ||
| Q4 24 | 4.29× | 1.14× | ||
| Q3 24 | 10.95× | 0.53× | ||
| Q2 24 | 4.51× | 5.54× | ||
| Q1 24 | -0.38× | 1.50× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CXDO
| Services | $8.6M | 48% |
| Software Solution Segment | $8.3M | 46% |
| Products | $1.1M | 6% |
FONR
| Managementof Diagnostic Imaging Centers | $23.2M | 91% |
| Manufacturingand Servicingof Medical Equipment | $2.4M | 9% |
